Welcome to The Multiple Sclerosis Journey. Join us for a multimedia exploration of where MS treatment and research stands, what the future of care may hold, and the experiences of clinicians and patients as they collaborate on the frontlines of MS care.
The Multiple Sclerosis Journey will examine new insights on the importance of early diagnosis as well as accurate identification of the four MS phenotypes and how their recognition impacts treatment selection. Join us as we examine the importance of maintaining brain health in sustaining wellness and ability among patients with MS. Experience discussions of the role of patient and physician collaboration in sustaining continuity of care and in tailoring therapy to individual patient needs and preferences.

And, importantly, view the impact of MS through the eyes of individual patients who generously tell their stories of how they build their lives around their abilities, not their disabilities.

The road to a cure for MS lies ahead. Along the way, clinicians, physicians, and patients are sharing their stories of working toward that goal at The Multiple Sclerosis Journey. We invite you to join them.

Walk with us.

Featured Articles

With studies lacking, expert opinion leads guidance for DMT therapy in MS during the COVID-19 pandemic

As the COVID-19 pandemic remains steadfast, medical communities continue seeking updated guidance on how the outbreak affects their respective patient populations, and multiple sclerosis (MS) is no exception.

Improving cognition in MS: Time to start prescribing exercise?

Exercising the mind through cognitive rehabilitation is now a recommended intervention for the many individuals with multiple sclerosis (MS) who experience difficulties with memory, thinking, and other brain functions. Could exercising the body be too far behind?

COViMS registry collects data on patients with MS and COVID-19

More than 4 months after it was established, the COViMS (COVID-19 Infections in Multiple Sclerosis and Related Diseases) database includes information about nearly 900 patients. The Consortium of Multiple Sclerosis Centers (CMSC) and the National Multiple Sclerosis Society (NMSS) initiated the database in April to gather information about COVID-19 infections and outcomes in North American patients with multiple sclerosis (MS) and other CNS demyelinating disorders.

Comorbidities in MS: Prevalence, Impact, and Management

Comorbidities are common in patients with multiple sclerosis (MS), can impact treatment decisions, and require a multidisciplinary approach to management, including careful attention to lifestyle issues, said Patricia Melville, RN, MSN, NP-C, MSCN, in a presentation at the virtual annual meeting of the Consortium of Multiple Sclerosis Centers (CMSC).

Pilot study tells two stories of aging with MS

For individuals with multiple sclerosis the experience of aging appears to follow along one of two paths – some people feel their preexisting disability gives them an advantage in coping and tolerating age-related difficulties, while others feel more acutely the double burdens of MS and aging.